Cardiac 123I-MIBG scintigraphy in patients with essential tremor

Mov Disord. 2006 Aug;21(8):1235-8. doi: 10.1002/mds.20908.

Abstract

In some cases, it is difficult to differentiate essential tremor (ET) from Parkinson's disease (PD), especially in the early stages of the disease. We investigated cardiac sympathetic dysfunction using (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in 22 patients with ET, in comparison with early PD and tremor-dominant PD (TDPD). The mean ratio of (123)I-MIBG uptake in the region of interest in the heart to that in the mediastinum (H/M ratio) was significantly greater in patients with ET (1.99 +/- 0.21) than in those with either TDPD (1.28 +/- 0.11) or early PD (1.28 +/- 0.17; each P < 0.001). The H/M ratio in all patients with ET was greater than two standard deviations above the range of the ratio in the patients with early PD or TDPD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Iodobenzylguanidine*
  • Aged
  • Aged, 80 and over
  • Diagnosis, Differential
  • Essential Tremor / diagnostic imaging*
  • Essential Tremor / physiopathology*
  • Female
  • Heart / diagnostic imaging*
  • Heart Diseases / diagnostic imaging
  • Heart Diseases / epidemiology
  • Humans
  • Iodine Radioisotopes*
  • Male
  • Middle Aged
  • Parkinson Disease / diagnostic imaging*
  • Parkinson Disease / physiopathology*
  • Radionuclide Imaging
  • Radiopharmaceuticals

Substances

  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine